+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030 - Product Thumbnail Image

U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030

  • Report
  • December 2022
  • 196 Pages
  • United States
From
Global Prostate Cancer Testing Market - A Regional and Country Analysis: Focus on Test Type, Application, End User, and Region - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

Global Prostate Cancer Testing Market - A Regional and Country Analysis: Focus on Test Type, Application, End User, and Region - Analysis and Forecast, 2022-2032

  • Report
  • December 2022
  • 223 Pages
  • Global
From
Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecasts to 2026 - Product Thumbnail Image

Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecasts to 2026

  • Report
  • December 2021
  • 95 Pages
  • Global
From
Prostate Cancer Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Zytiga, Gonax, Lupron, Zoladex, Decapeptyl, Eligard, Vantas, Casodex, Xtandi), by Distribution Channel, by Region, and Segment Forecasts, 2022-2030 - Product Thumbnail Image

Prostate Cancer Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Zytiga, Gonax, Lupron, Zoladex, Decapeptyl, Eligard, Vantas, Casodex, Xtandi), by Distribution Channel, by Region, and Segment Forecasts, 2022-2030

  • Report
  • October 2022
  • 80 Pages
  • Global
From
Drug Overview: Yonsa - Product Thumbnail Image

Drug Overview: Yonsa

  • Drug Pipelines
  • January 2018
  • 13 Pages
  • Global
From
Drug Overview: Xofigo - Product Thumbnail Image

Drug Overview: Xofigo

  • Drug Pipelines
  • January 2018
  • 16 Pages
  • Global
From
Drug Overview: Provenge - Product Thumbnail Image

Drug Overview: Provenge

  • Drug Pipelines
  • January 2018
  • 13 Pages
  • Global
From
Drug Overview: Zoladex - Product Thumbnail Image

Drug Overview: Zoladex

  • Drug Pipelines
  • January 2018
  • 8 Pages
  • Global
From
Research Report on China's Bicalutamide Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Bicalutamide Market, 2021-2025

  • Report
  • November 2021
  • 40 Pages
  • China
From
Investigation Report on China's Capecitabine Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Capecitabine Market 2021-2025

  • Report
  • July 2021
  • 50 Pages
  • China
From
Investigation Report on China's Goserelin Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Goserelin Market 2021-2025

  • Report
  • June 2021
  • China
From
Investigation Report on China's Docetaxel Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Docetaxel Market 2021-2025

  • Report
  • June 2021
  • 50 Pages
  • China
From
Investigation Report on China's Abiraterone Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Abiraterone Market 2021-2025

  • Report
  • May 2021
  • 50 Pages
  • China
From
United States Prostate Cancer Testing Market by Biomarker Type, Application, End-user, Region, Competition Forecast & Opportunities, 2018-2028 - Product Thumbnail Image

United States Prostate Cancer Testing Market by Biomarker Type, Application, End-user, Region, Competition Forecast & Opportunities, 2018-2028

  • Report
  • July 2023
  • 78 Pages
  • United States
From
Castrate Resistant Prostate Cancer Therapeutics Market - Growth, Trends And Forecasts (2022 - 2027) - Product Thumbnail Image

Castrate Resistant Prostate Cancer Therapeutics Market - Growth, Trends And Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 112 Pages
  • Global
From
Capecitabine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Capecitabine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 121 Pages
  • Global
From
Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 432 Pages
  • Global
From
Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • November 2023
  • 230 Pages
  • Global
From
Benign Prostatic Hyperplasia- Market Insight, Competitive Landscape and Market Forecast, 2027 - Product Thumbnail Image

Benign Prostatic Hyperplasia- Market Insight, Competitive Landscape and Market Forecast, 2027

  • Report
  • July 2022
  • 100 Pages
  • Global
From
Metastatic Castration-Sensitive Prostate Cancer (mCSPC) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Metastatic Castration-Sensitive Prostate Cancer (mCSPC) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 160 Pages
  • Global
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more